TruAlt Bioenergy Limited delivered a robust financial performance for the first quarter of FY27, reporting a profit after tax (PAT) of ₹59.3 crore, a surge of over 1,000% year-on-year from ₹4.7 crore. The company’s revenue from operations reached ₹626.90 crore in the ethanol segment, growing 106.3% quarter-on-quarter, supported by higher production volumes and improved capacity utilization following the conversion of three plants to dual-feed operations.

The earnings call transcript, filed with BSE and NSE on August 4, 2026, under Regulation 30(6) of SEBI LODR Regulations, details the operational drivers behind this growth. Managing Director Vijaykumar Murugesh Nirani and CFO Anand Kishore highlighted that the company produced close to 8.5 crore litres of ethanol, achieving sales of a similar volume. The shift to grain-based feedstock, particularly maize procured at lower prices earlier in the season, significantly boosted margins. EBITDA stood at ₹147.3 crore, up 129% quarter-on-quarter, with an EBITDA margin of 23.5%.

Financial Highlights

The cost structure showed efficiency gains, with finance costs reducing to 7% of revenue from 12.4% in the previous quarter. Employee costs also declined to 1.9% from 3.7% year-on-year. Raw materials constituted 53.2% of revenue, while inventory accounted for 7.6%. The balance sheet reflects segmental assets of ₹3,754 crore against liabilities of ₹2,074 crore, maintaining a debt-equity ratio of 0.59 and an asset coverage ratio of 1.81x.

Operational Drivers and Capacity Utilization

The primary driver for the margin expansion was the successful transition to dual-feed operations, allowing the company to utilize cheaper grain-based feedstocks alongside sugar-based ones. CFO Anand Kishore noted that grain-based feedstock offers a 6% better profit margin compared to sugar-based feedstocks, with higher yields of approximately 450 litres per ton versus 317 litres for sugar content. Currently, the company operates at about 60% capacity utilization, with plans to increase this by another 20-25% in coming quarters. A pending court case regarding an additional 15 crore litres of ethanol capacity could further boost utilization to 90-95%.

In the compressed biogas (CBG) vertical, the company reported revenue of ₹11.2 crore and a PAT of ₹4-4.5 crore, maintaining healthy margins of 40-45%. Three out of four planned CBG plants under the joint venture with Sumitomo are near commissioning, expected to contribute to revenues by Q3 FY27. Additionally, six locations have been identified for JV with GAIL, with construction set to begin in August 2026.

What the Numbers Show

The significant leap in profitability is not merely volume-driven but structurally enhanced through feedstock optimization. The ability to procure maize at ₹18-21 per kg during the October-January period, compared to current prices of ₹25.50, provided a substantial margin buffer. This strategic inventory management, combined with the dual-feed flexibility, insulated the company from recent raw material price hikes. Furthermore, the reduction in finance costs as a percentage of revenue indicates improved operational leverage and efficient capital deployment post-IPO. The company’s focus on diversifying into CBG and sustainable aviation fuel (SAF), backed by ₹150 crore in viability gap funding under PM JI-VAN Yojana, positions it for sustained growth beyond traditional ethanol production.

TruAlt Bioenergy has appointed Mr. Deepak Sadhu as its Secretarial Auditor for a period of five consecutive years, effective from April 01, 2026, through March 31, 2031. The Board of Directors approved the appointment during a meeting held on Tuesday, August 4, 2026, citing the firm’s expertise in corporate laws and governance as beneficial to the company’s interests. This engagement ensures continuity in regulatory compliance monitoring over the next fiscal cycle.

The appointment was made in accordance with Regulation 24(A) and Regulation 30 read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/015 dated November 11, 2024, and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, in its disclosure to the stock exchanges.

Mr. Sadhu is a Practicing Company Secretary based in Bangalore, holding ACS number 39541 and COP number 14992. He possesses an overall 11 years of professional experience spanning corporate laws, governance, secretarial audit, intellectual property, and transaction advisory. His profile indicates he has served as a trusted advisor to more than 150 companies.

Auditor Profile and Experience

Mr. Sadhu’s professional background includes roles as a Compliance Advisor for the Kurl-on Group and engagements with listed entities such as Natural Capsules Limited and KMF Builders & Developers Limited. His expertise covers corporate compliance, board and shareholder advisory, mergers and acquisitions, business takeovers, due diligence, and strategic transactions. Additionally, he provides end-to-end trademark services, including applications, objections, hearings, registrations, renewals, restorations, and portfolio management.

The Board confirmed that Mr. Deepak Sadhu is not related to any Director of the Company, ensuring independence in the audit function. The meeting commenced at 10:50 a.m. IST and concluded at 12:10 p.m. IST. The company disclosed that this information is available on its website at www.trualtbioenergy.com .

What This Means for Governance

The appointment of a long-term secretarial auditor provides stability to TruAlt Bioenergy’s compliance framework. With a five-year tenure, Mr. Sadhu will oversee adherence to statutory requirements across multiple financial years, reducing the administrative burden of frequent auditor changes. His specific experience with listed companies like Natural Capsules Limited suggests familiarity with the rigorous disclosure norms applicable to public entities.